Test-and-treat approach to HIV/AIDS: a primer for mathematical modeling

被引:18
|
作者
Nah, Kyeongah [1 ,2 ]
Nishiura, Hiroshi [1 ,2 ]
Tsuchiya, Naho [3 ]
Sun, Xiaodan [1 ,4 ]
Asai, Yusuke [1 ,2 ]
Imamura, Akifumi [5 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan
[2] Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan
[3] Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan
[4] Xi An Jiao Tong Univ, Dept Appl Math, Xian 710049, Shaanxi, Peoples R China
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Infect Dis, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; UNITED-STATES; PREVENTION; INFECTION; ELIMINATION; STRATEGY; UGANDA; IMPACT; STAGE;
D O I
10.1186/s12976-017-0062-9
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The public benefit of test-and-treat has induced a need to justify goodness for the public, and mathematical modeling studies have played a key role in designing and evaluating the test-and-treat strategy for controlling HIV/AIDS. Here we briefly and comprehensively review the essence of contemporary understanding of the test-and-treat policy through mathematical modeling approaches and identify key pitfalls that have been identified to date. While the decrease in HIV incidence is achieved with certain coverages of diagnosis, care and continued treatment, HIV prevalence is not necessarily decreased and sometimes the test-and-treat is accompanied by increased long-term cost of antiretroviral therapy (ART). To confront with the complexity of assessment on this policy, the elimination threshold or the effective reproduction number has been proposed for its use in determining the overall success to anticipate the eventual elimination. Since the publication of original model in 2009, key issues of test-and-treat modeling studies have been identified, including theoretical problems surrounding the sexual partnership network, heterogeneities in the transmission dynamics, and realistic issues of achieving and maintaining high treatment coverage in the most hard-to-reach populations. To explicitly design country-specific control policy, quantitative modeling approaches to each single setting with differing epidemiological context would require multi-disciplinary collaborations among clinicians, public health practitioners, laboratory technologists, epidemiologists and mathematical modelers.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Honing the Test-and-Treat HIV Strategy
    Mastro, Timothy D.
    Cohen, Myron S.
    SCIENCE, 2010, 328 (5981) : 976 - 976
  • [2] 'Test-and-treat': the end of the HIV epidemic?
    Cambiano, Valentina
    Rodger, Alison J.
    Phillips, Andrew N.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (01) : 19 - 26
  • [3] Prospects of elimination of HIV with test-and-treat strategy
    Kretzschmar, Mirjam E.
    van der Loeff, Maarten F. Schim
    Birrell, Paul J.
    De Angelis, Daniela
    Coutinho, Roel A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (39) : 15538 - 15543
  • [4] Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model
    Luo, Sitong
    Han, Litao
    Lu, Hongyan
    Dou, Zhi
    Tao, Qian
    Khoshnood, Kaveh
    Wu, Zunyou
    Xu, Jie
    PLOS ONE, 2015, 10 (06):
  • [5] Test-and-Treat in Los Angeles: A Mathematical Model of the Effects of Test-and-Treat for the Population of Men Who Have Sex With Men in Los Angeles County
    Sood, Neeraj
    Wagner, Zachary
    Jaycocks, Amber
    Drabo, Emmanuel
    Vardavas, Raffaele
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1789 - 1796
  • [6] "Test-and-Treat" Strategy for Control of HIV and AIDS Can Lead to a Decrease, Not an Increase, of Multidrug-Resistant Viruses
    Gonzalez-Serna, A.
    Lima, V. D.
    Montaner, J. S.
    Harrigan, P. R.
    Brumme, C. J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) : 478 - U200
  • [7] Strengthening universal HIV 'test-and-treat' approaches with social science research
    Camlin, Carol S.
    Seeley, Janet
    Viljoen, Lario
    Vernooij, Eva
    Simwinga, Musonda
    Reynolds, Lindsey
    Reis, Ria
    Plank, Rebeca
    Orne-Gliemann, Joanna
    McGrath, Nuala
    Larmarange, Joseph
    Hoddinott, Graeme
    Getahun, Monica
    Charlebois, Edwin D.
    Bond, Virginia
    AIDS, 2016, 30 (06) : 969 - 970
  • [8] Addressing the Achilles' Heel in the HIV Care Continuum for the Success of a Test-and-Treat Strategy to Achieve an AIDS-Free Generation
    Nachega, Jean B.
    Uthman, Olalekan A.
    del Rio, Carlos
    Mugavero, Michael J.
    Rees, Helen
    Mills, Edward J.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 : S21 - S27
  • [9] "Test-and-Treat" Strategy for Control of HIV and AIDS Can Lead to a Decrease, Not an Increase, of Multidrug-Resistant Viruses Reply
    Sood, Neeraj
    Wagner, Zachary
    Jaycocks, Amber
    Drabo, Emmanuel
    Vardavas, Raffaele
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) : 479 - U202
  • [10] The temporalities of policymaking: The case of HIV test-and-treat policy adoption in Zimbabwe
    Moran, Meg
    Skovdal, Morten
    Mpandaguta, Edith
    Maswera, Rufurwokuda
    Kadzura, Noah
    Dzamatira, Freedom
    Nyamukapa, Constance
    Gregson, Simon
    Tlhajoane, Malebogo
    HEALTH & PLACE, 2020, 61